Ulrike Gerdemann

机构：Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute · ORCID：0000-0002-3600-0366

发表论文 134 篇 · 总被引 4029 次 · h-index 24

代表论文

• Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity (2024 · Science Translational Medicine · 被引 37)
• B-cell–directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primates (2024 · Blood · 被引 24)
• A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL). (2024 · Journal of Clinical Oncology · 被引 21)
• Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate–conditioned Fanconi anemia mice (2024 · Blood · 被引 10)
• Organ-specific microenvironments drive divergent T cell evolution in acute graft-versus-host disease (2025 · Science Translational Medicine · 被引 6)
• A single dose of a CD137 antibody–drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD (2025 · Blood · 被引 5)